Johnson Pharmacare share news, announcements and annual reports
BSE: 532154Commercial Services & SuppliesSmall Cap
JOHNSON PHARMACARE LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1997
Last close ₹0.37₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.37.
30 Oct: open ₹0.38, high ₹0.38, low ₹0.36
52-week range of traded prices to 30 Oct 2026
₹0.36Low, 29 Oct 2026₹0.70High, 24 Nov 2025
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹20 Cr3,837th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 46.76
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −200.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹14 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −150.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −195.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 49.18
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 7,61,670
Johnson Pharmacare board meetings
125 filed, newest first. Page 1 of 3.
Aug 2026
10 Aug · Board meeting
Meeting on 13 Aug 2026: quarterly results
May 2026
22 May · Board meeting
Meeting on 27 May 2026: audited results
Apr 2026
17 Apr · Board meeting
Meeting on 17 Apr 2026
Feb 2026
12 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results5 Feb · Board meeting
Meeting on 12 Feb 2026: quarterly resultsNot held on this date
Jan 2026
Nov 2025
24 Nov · Board meeting
Meeting on 24 Nov 202524 Nov · Board meeting
12 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Jul 2025
16 Jul · Board meeting
Meeting on 23 Jul 2025: quarterly results
May 2025
12 May · Board meeting
Meeting on 23 May 2025: audited results
Jan 2025
21 Jan · Board meeting
Meeting on 31 Jan 2025: quarterly results
Oct 2024
15 Oct · Board meeting
Meeting on 13 Nov 2024: quarterly results
Aug 2024
Jul 2024
25 Jul · Board meeting
Meeting on 1 Aug 2024: quarterly results
May 2024
25 May · Board meeting
16 May · Board meeting
Meeting on 25 May 2024: audited results
Jan 2024
16 Jan · Board meeting
Meeting on 22 Jan 2024: quarterly results
Nov 2023
Oct 2023
26 Oct · Board meeting
Meeting on 1 Nov 2023: quarterly results
Aug 2023
3 Aug · Board meeting
Meeting on 10 Aug 2023: quarterly results
May 2023
18 May · Board meeting
Meeting on 24 May 2023: audited results
Feb 2023
Jan 2023
27 Jan · Board meeting
Meeting on 2 Feb 2023: quarterly results